Bausch Health Companies Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Large accelerated filer
State of Incorporation
NJ
Business Address
2150 ST. ELZEAR BLVD. WEST, QUEBEC, A8, H7L 4A8
Mailing Address
2150 ST. ELZEAR BLVD. WEST, QUEBEC, A8, H7L 4A8
Phone
514-744-6792
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2025
$157.00M
Net Income
$0.42
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 8-K Current report of material events | March 2, 2026 | View on SEC |
| 4 Insider stock transaction report | February 27, 2026 | View on SEC |
| 4 Insider stock transaction report | February 27, 2026 | View on SEC |
| 4 Insider stock transaction report | February 27, 2026 | View on SEC |
| 4 Insider stock transaction report | February 27, 2026 | View on SEC |
| 4 Insider stock transaction report | February 27, 2026 | View on SEC |
| 10-K Annual financial report | February 19, 2026 | View on SEC |
Annual Reports
10-K
February 19, 2026
- Bausch Health is strategically strengthening its Bausch + Lomb eye health business through significant acquisitions, aiming for long-term growth and market leadership.
- Despite a net loss, the company achieved an Adjusted EBITDA of approximately $3.5 billion, indicating underlying operational strength in its core businesses.
Insider Trading
SELL
1 insiders
3 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.